基于网络药理学研究温中补肾方改善小鼠卵巢储备下降的作用与机制
温中补肾方(WZBSF)是临床用于治疗卵巢储备下降(DOR)的中药经验方,但其药理机制尚不明确。本研究整合网络药理学与动物实验,发现WZBSF与DOR共有145个交集靶点,富集于PI3K-AKT和FoxO信号通路;在环磷酰胺和白消安诱导的DOR小鼠模型中,WZBSF可恢复体重增长率、卵巢指数、动情周期、血清激素及卵泡计数,并降低p-AKT和p-FOXO3a水平,抑制原始卵泡过度激活。
要点
- WZBSF与卵巢储备下降共有145个交集靶点,涉及PI3K-AKT和FoxO信号通路。
- WZBSF可恢复DOR小鼠的体重增长率、卵巢指数、动情周期及血清激素平衡。
- WZBSF通过降低p-AKT和p-FOXO3a水平抑制原始卵泡过度激活,维持卵巢储备。
核心结论
- WZBSF可改善环磷酰胺和白消安诱导的小鼠卵巢储备下降。
- 其机制可能与抑制PI3K/AKT/FOXO3a信号通路有关。
研究设计与样本
- 研究采用网络药理学与动物实验相结合的方法。
- 使用UPLC-MS/MS和GC-MS双平台分析WZBSF成分。
- 从TCMSP数据库获取有效成分和靶点,经UniProt标准化。
- 疾病靶点来自GeneCard、OMIM、PHARMGKB和DisGeNET数据库。
- 建立小鼠卵巢储备下降模型,给予不同剂量WZBSF,通过血清激素检测、H&E染色、免疫荧光、免疫组化和Western blot验证。
主要发现
- WZBSF与卵巢储备下降共有145个共同靶点。
- GO富集分析涉及对激素刺激的反应和磷酸酶结合等生物过程。
- KEGG分析涉及PI3K-AKT信号通路和FoxO信号通路。
- 在DOR小鼠中,WZBSF恢复体重增长率、增加卵巢指数、恢复正常动情周期、逆转血清激素失衡、恢复各类卵泡计数并改善卵巢形态。
- WZBSF降低p-AKT和p-FOXO3a水平,防止原始卵泡过度激活并维持卵巢储备。
临床怎么用
- WZBSF可能作为改善卵巢储备下降的潜在中药方剂,其作用与抑制PI3K/AKT/FOXO3a通路相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: The Wenzhong Bushen Formula (WZBSF) is a traditional Chinese medicine empirical formula known for its effects in tonifying qi, strengthening the spleen, warming the kidneys, promoting yang, regulating blood circulation, and balancing menstruation. Clinical evidence has demonstrated its significant efficacy in treating Diminished Ovarian Reserve (DOR) by improving ovarian reserves. However, the specific pharmacological mechanisms of WZBSF remain unclear. AIM OF THE STUDY: This study aims to investigate the mechanisms by which WZBSF improves ovarian reserve decline through network pharmacology and animal experiments. METHODS AND MATERIALS: WZBSF was analyzed using a dual UPLC-MS/MS and GC-MS platform. Effective components and targets of WZBSF were obtained from the TCMSP database and standardized using UniProt. Disease targets were collected from GeneCard, OMIM, PHARMGKB, and DisGeNET databases, with cross-referencing between the two sets of targets. A PPI protein interaction network was constructed using Cytoscape3.9.1 and STRING database, followed by KEGG and GO enrichment analysis using the Metascape database. Finally, an ovarian reserve decline model was established in mice, different doses of WZBSF were administered, and experimental validation was conducted through serum hormone detection, H&E staining, immunofluorescence (IF), immunohistochemistry (IHC), and Western blot analysis (WB). RESULTS: WZBSF shares 145 common targets with ovarian reserve decline. GO enrichment analysis revealed involvement in biological processes such as response to hormone stimulation and phosphatase binding, while KEGG analysis implicated pathways including the PI3K-AKT signaling pathway and FoxO signaling pathway. In mice with ovarian reserve decline, WZBSF restored weight gain rate, increased ovarian index, normalized estrous cycles, reversed serum hormone imbalances, restored various follicle counts, and improved ovarian morphology. Additionally, WZBSF reduced p-AKT and p-FOXO3a levels, preventing excessive activation of primordial follicles and maintaining ovarian reserve. CONCLUSION: WZBSF can ameliorate cyclophosphamide and busulfan-induced ovarian reserve decline, and its mechanism may be associated with the inhibition of the PI3K/AKT/FOXO3a signaling pathway.
引用
- Liang X, Xie H, Yu L, et al. Study on the effects and mechanisms of Wenzhong Bushen Formula in improving ovarian reserve decline in mice based on network pharmacology. J Ethnopharmacol. 2024. PMID: 38218503. doi:10.1016/j.jep.2024.117756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。